Citation

Nižnanská, Hengerics Szabó A, Masár M, Szucs R, Šikuta J, Nižnanský. Int. J. Mol. Sci. 2024; 25(10): e5202.

Copyright

(Copyright © 2024, Molecular Diversity Preservation International)

DOI

10.3390/ijms25105202

PMID

38791240

Abstract

Propafenone (PPF) belongs to the class 1C antiarrhythmics and can cause electrocardiogram-associated adverse/toxic effects. Cases of PPF intoxication are rarely investigated. We developed a novel and selective GC-MS/MS method for the determination of PPF and its tissue distribution in an intentional fatal poisoning case, which is applicable to PPF quantification in the range of therapeutic to lethal concentrations in complex post-mortem samples. A simple and effective sample pretreatment was applied to all analyzed samples. PPF was determined without the need for dilution, even in highly complex samples containing a wide range of analyte concentrations. Quantification was performed using the standard addition method, developed and validated according to the ICH M10 guidelines. The obtained results indicated that the PPF concentration in the serum from blood taken while alive, before therapy, was the highest ever reported in the literature. Despite the intensive therapy after the patients' admission, the PPF concentrations in the lungs, spleen, femoral blood and cardiac blood were fatal or abnormally high. On the other hand, the concentrations in the liver and skeletal muscle were lower or approximately the same as observed in cases with therapeutic doses. To the best of our knowledge, the distribution of PPF has not been investigated in fatal intoxication cases and can be helpful in clinical or forensic toxicology.

Language: en

Keywords

*Propafenone/poisoning; Adult; Anti-Arrhythmia Agents/poisoning; Fatal Outcome; Gas Chromatography-Mass Spectrometry; GC-MS/MS; Humans; intoxication; Male; poisoning; propafenone; suicide; Tandem Mass Spectrometry; tissue distribution; Tissue Distribution; toxicology